Tesamorelin 5 mg/Ipamorelin 5 mg

Peptide Hubs Tesamorelin/Ipamorelin

Unleash the full potential of your endogenous growth hormone axis with the meticulously engineered Peptide Hubs Tesamorelin/Ipamorelin 10 mg blend. This premium combination pairs the visceral-fat-targeting power of Tesamorelin (a GHRH analogue) with the clean, hunger-free amplification of Ipamorelin (a GHRP), creating what many consider the perfect growth hormone secretagogue stack. Designed for athletes seeking superior body recomposition, this synergistic blend promotes a powerful, natural GH pulse that facilitates deep fat loss, lean muscle accrual, and enhanced recovery—all without the unwanted side effects of cortisol spikes or increased appetite. Backed by multiple third-party lab tests verifying the precise 5 mg/5 mg ratio, this legit Peptide Hubs product offers unmatched convenience and efficacy. When you buy Tesamorelin/Ipamorelin by Peptide Hubs, you're investing in a clinically-informed, precision-tool for transformative physique enhancement.

Tesamorelin/Ipamorelin Composition

Each 2 mL vial contains a precisely balanced 1:1 ratio of two high-purity peptides: 5 mg of Tesamorelin (a modified 44-amino acid GHRH analogue) and 5 mg of Ipamorelin (a pentapeptide GHRP), for a total of 10 mg of active lyophilized powder. This formulation is optimized to deliver simultaneous agonism at both the Growth Hormone-Releasing Hormone receptor and the Ghrelin receptor, ensuring maximal synergistic release of endogenous Growth Hormone.

Bodybuilding & Athletic Benefits

This blend is a cornerstone for serious physique transformation. The synergy delivers compounded benefits: Tesamorelin drives a significant reduction in stubborn visceral and abdominal fat, dramatically improving definition and vascularity. Ipamorelin amplifies this GH pulse, further enhancing lipolysis while simultaneously promoting lean muscle growth through increased protein synthesis and IGF-1 levels. Users experience drastically improved recovery times between workouts, deeper and more restorative sleep, enhanced joint and tendon health, and better skin quality. The result is a harder, leaner, and more muscular physique with improved insulin sensitivity and metabolic function, making it ideal for both cutting phases and lean bulking cycles.

Therapeutic Indication

Individually, both peptides have strong therapeutic foundations. Tesamorelin is FDA-approved for reducing excess abdominal fat in HIV-associated lipodystrophy, with clinical studies demonstrating its specific action on visceral adipose tissue and metabolic parameters. Ipamorelin, known for its selectivity, has been researched for its potential in treating growth hormone deficiency without adversely affecting other pituitary hormones. The combination is of interest in anti-aging medicine for its potential to restore youthful GH pulsatility, improve body composition, and enhance cellular repair. Research on GHRH/GHRP synergy highlights its efficacy in safely restoring the somatotropic axis.

Dosage (Men)

The standard and highly effective protocol for men is 1 mg of each peptide (2 mg total) administered via subcutaneous injection once daily, typically 30-60 minutes before bedtime to align with the body's natural nocturnal GH surge. For those seeking more aggressive results, a dose of 1.5 mg of each peptide (3 mg total) can be used. The blend should be reconstituted immediately before injection for maximum Tesamorelin stability. Cycles typically last 12-16 weeks.

Dosage (Women)

Female users respond excellently to this blend. The recommended starting dose is 1 mg of each peptide (2 mg total) once daily before bed. Some women may find an effective dose at 0.75 mg of each (1.5 mg total), especially those of smaller stature or when first initiating therapy. The evening dosing schedule is crucial for both genders to maximize the natural rhythm of GH release.

Active Life

Tesamorelin has a plasma half-life of approximately 26-38 minutes, while Ipamorelin's half-life is about 2 hours. However, their biological effect—the stimulated release of Growth Hormone and subsequent increase in IGF-1—persists for many hours. The combination produces a robust GH pulse that, when administered in the evening, supports the anabolic and reparative processes of the overnight fasting period.

Tesamorelin/Ipamorelin Side Effects

This blend is exceptionally well-tolerated, combining the favorable safety profiles of both peptides. The most common side effects are mild injection site reactions. Ipamorelin is notably free from the increased hunger and cortisol/ prolactin spikes associated with other GHRPs like GHRP-6. Tesamorelin may rarely cause transient joint pain or stiffness. Systemic side effects are uncommon but could include mild headache or dizziness shortly after injection. There is no significant impact on blood glucose levels.

Tesamorelin/Ipamorelin Contraindications/Precautionary Measures

Contraindicated in individuals with active malignancy, known hypersensitivity to either peptide, or untreated pituitary disorders. Use with caution in those with diabetes or impaired glucose tolerance, and monitor blood sugar initially. Not recommended during pregnancy or breastfeeding. Due to Tesamorelin's potential to increase IGF-1, it should be avoided in individuals with active proliferative diabetic retinopathy. As with any GH-affecting compound, those with a history of cancer should exercise extreme caution and consult a physician.

Overdosage

Overdosing would likely amplify the known side effects, potentially leading to more pronounced joint pain, headache, or injection site reactions. There is a theoretical risk of excessively elevated GH/IGF-1 levels, which could lead to symptoms like carpal tunnel syndrome, arthralgia, or fluid retention. However, due to the natural pulsatile release mechanism, the risk of creating supraphysiological IGF-1 levels seen with exogenous GH is much lower. Treatment is discontinuation and symptomatic support.

Tesamorelin/Ipamorelin Stack/Cycle

This powerful base blend can be further enhanced for specific goals. For accelerated fat loss, particularly targeting stubborn areas, stack with AOD 9604 5 mg. To support connective tissue health and injury recovery during intense training, add TB 500 5 mg. For comprehensive cellular repair, mitochondrial support, and anti-aging benefits, combine with SS-31 50 mg. To potentiate muscle growth and localized recovery, consider adding PEG MGF 5 mg. For a nootropic edge and cognitive support alongside physical enhancement, Semax 5 mg makes an excellent complementary peptide.

Package Presentation

Your order arrives in secure, discreet packaging. Each purchase contains one sealed 2 mL glass vial filled with 10 mg of the pre-blended, lyophilized Tesamorelin and Ipamorelin peptide powder from Peptide Hubs.

Storage

Store the unopened, lyophilized vial in a refrigerator between 2°C and 8°C (36°F - 46°F). Protect from light and moisture. Due to the Tesamorelin component's stability profile, this blend should be reconstituted with bacteriostatic water immediately before injection and used promptly. Do not store the reconstituted solution for later use; discard any unused portion to ensure optimal potency and sterility.

Tesamorelin/Ipamorelin Referrers

This blend creates a powerful synergistic effect on the hypothalamic-pituitary-somatotropic axis through two distinct but complementary mechanisms. Tesamorelin acts as a potent agonist at the GHRH receptor on pituitary somatotrophs, stimulating the cAMP pathway and promoting the synthesis and release of Growth Hormone. Its modified structure provides a specific signal for GH production. Ipamorelin is a selective agonist for the ghrelin (GHSR-1a) receptor. Its binding potentiates the GH release triggered by GHRH through the phospholipase C/IP3 pathway, and it also exhibits somatostatin antagonism, temporarily reducing the inhibitory brake on GH secretion. Together, they provide a dual signal: Tesamorelin "primes" the pituitary and sets the direction, while Ipamorelin "amplifies" the release by removing inhibition and adding a potentiating signal. This results in a larger, more physiological GH pulse than either could achieve alone.

Third-Party Lab Test

2026-01-12

View Result

5.14 mg/4.24 mg

2025-09-29

View Result

5.04 mg/4.75 mg